Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 3 , Pages 202-212 , September 2007

Interstitial in vivo ALA-PpIX mediated metronomic photodynamic therapy (mPDT) using the CNS-1 astrocytoma with bioluminescence monitoring

  • Nick Davies, BSc (Hons), MSc

      Affiliations

    • Department of Medical Biophysics, University of Toronto, 610 University Avenue, Toronto, Canada M5G 2M9
    • Corresponding Author InformationCorresponding author.
    • ,
  • Brian C. Wilson

      Affiliations

    • Department of Medical Biophysics, University of Toronto, 610 University Avenue, Toronto, Canada M5G 2M9
    • Ontario Cancer Institute, University Health Network, 610 University Avenue, Toronto, Canada M5G 2M9

References 

  1. Zimmermann A, Ritsch-MKarte M, Kostron H. mTHPC-mediated photodynamic diagnosis of malignant brain tumors. Photochem Photobiol. 2001;74:611–616
  2. Stylli SS, Kaye AH. Photodynamic therapy of cerebral glioma—a review. Part II. Clinical studies. J Clin Neurosci. 2006;7:709–717
  3. Shapiro WR. Current therapy for brain tumors. Arch Neurol. 1999;56:429–432
  4. La Croix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190–198
  5. Murray KJ. Improved surgical resection of human brain tumors. Part I. A preliminary study. Surg Neurol. 1982;17:316–319
  6. Poon WS, Schomacker KT, Deutsch TF, Martuza RL. Laser induced fluorescence: experimental intra-operative delieation of tumor resection margins. J Neurosurg. 1992;76:679–686
  7. Stummer W, Stepp H, Moller G, Ehrhardt A, Leonard M, Reulen HJ. Technical principles for protoporphyrin-ix-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir. 1998;140:995–1000
  8. Bogaards A, Varma A, Collens SP, et al. Increased brain tumor resection using fluorescence guidance in a preclinical model. Lasers Surg Med. 2004;35:181–190
  9. Boggards A, Varma A, Zhang K, et al. Fluorescence image-guided brain tumor resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development. Photochem Photobiol Sci. 2005;4:438–442
  10. MacDonald IJ, Dougherty TJ. Basic principles of photodynamic therapy. J Porphyr Phtalocyan. 2001;5:105–129
  11. Powers SK, Cush SS, Walstad DL, Kwock L. Stereotactic intratumoral photodynamic therapy for recurrent malignant brain tumours. Neurosurgery. 1991;29:688–695
  12. Muller PJ, Wilson BC. Photodynamic therapy in primary brain tumours; clinical effects, postoperative ICP and light penetration of the brain. Photochem Photobiol. 1987;46:929–935
  13. Muller PJ, Wilson BS. Photodynamic therapy for recurrent supra tentorial gliomas. Semin Surg Oncol. 1995;11:346–354
  14. Stylli SS, Kaye AH, MacGregor L, Howes M, Rajendra P. Photodynamic therapy of high grade glioma-long term survival. J Clin Neurosci. 2005;12:389–398
  15. Chopp M, Dereski MO, Madigan V, Jiang F, Logie B. Sensitivity of 9L gliosarcomas to photodynamic therapy. Radiat Res. 1996;146:461–465
  16. Jiang F, Lilge L, Grenier J, Li Y, Wilson MD, Chopp M. Photodynamic therapy of U87 human glioma in nude rat using liposome-delivered Photofrin. Lasers Surg Med. 1997;22:74–78
  17. Jiang F, Lilge L, Logie B, Liand Y, Chopp M. Photodynamic therapy of 9L gliosarcoma with liposome-delivered. Photofrin Photochem Photobiol. 1997;65:701–706
  18. Kaye AH, Morstyn G, Brownbill D. Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma, a phase 1–2 study. J Neurosurg. 1987;67:500–505
  19. Chen Q, Chopp M, Dereski MO, et al. The effect of light fluence in photodynamic therapy of normal rat brain. Radiat Res. 1992;132:120–123
  20. Lilge L, Olivo MC, Schatz SW, Maguire JA, Patterson MS, Wilson BC. The sensitivity of normal brain and intracranially implanted VX2 tumor to interstitial photodynamic therapy. Br J Cancer. 1996;73:332–343
  21. Lilge L, Wilson BC. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. J Clin Laser Med Surg. 1998;16:81–91
  22. Ennis SR, Novotny A, Xiang J, et al. Transport of 5-ALA between blood and brain. Brain Research. 2003;959:226–234
  23. Wilson BC, Bisland S, Bogaards A, et al. Metronomic photodynamic therapy (mPDT): concepts and technical feasibility in brain tumor. Proc SPIE. 2003;4952:23–31
  24. Olivo M, Wilson BC. Mapping ALA-PPIX fluorescence in normal brain and brain tumour using confocal fluorescence microscopy. Int J Oncol. 2004;25:37–45
  25. Patterson MS, Wilson BC, Graff R. In vivo tests of the concept of photodynamic threshold dose in normal rat liver photosensitized by aluminum chlorosulphonated phthalocyanine. Photochem Photobiol. 1990;51:343–349
  26. Lilge L, Portnoy M, Wilson BC. Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumor tissue. Br J Cancer. 2000;83:1110–1117
  27. Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumor immunity. Nat Rev Cancer. 2006;6:535–545
  28. Chen Q, Chopp M, Madigan L, Dereski MO, Hetzel FW. Damage threshold of normal rat brain in photodynamic therapy. Photochem Photobiol. 1996;64:163–167
  29. Kerbel RS, Klement G, Pritchard KI, Kamen B. Continuous low-dose anti-angiogenic/metronomic chemotherapy: from the research laboratory into the oncology clinic. Ann Oncol. 2002;13:12–15
  30. Madsen SJ, Chung-Ho S, Tromberg BJ, Wallace VP, Hirschberg H. Photodynamic therapy of human glioma spheroids using 5-aminolevulinic acid. Photochem Photobiol. 2000;72:128–134
  31. Madsen SJ, Sun CH, Tromberg BJ, Hirschberg H. Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids. J Neurooncol. 2003;62:243–250
  32. Hirschberg H, Sorensen DR, Angell-Petersen E, et al. Repetitive photodynamic therapy of malignant brain tumors. J Environ Pathol Toxicol Oncol. 2006;25:261–280
  33. Angell-Petersen E, Spetalen S, Madsen SJ, et al. Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. J Neurosurg. 2006;104:109–117
  34. Bisland SK, Lilge L, Lin A, Wilson BC. Metronomic photodynamic therapy (mPDT) for intracranial neoplasm: physiological, biological, and dosimetry considerations. Proc SPIE. 2003;5142:9–17
  35. Van de Boogert J, van Hillegersberg R, de Rooij FW, et al. 5-Aminolaevulinic acid-induced protoporphyrin IX accumulation in tissues: pharmacokinetics after oral or intravenous administration. J Photochem Photobiol B: Biol. 1998;44:29–38
  36. Bisland SK, Lilge L, Lin A, Rusnov R, Bogaards A, Wilson BC. Metronomic photodynamic therapy as a new paradigm for photodynamic therapy: rationale and preclinical evaluation of technical feasibility for treating malignant brain tumors. Photochem Photobiol. 2004;80:22–30
  37. Kruse CA, Molleston MC, Parks EP, Schiltz PM, Kleinschmidt-DeMasters BK, Hickey WF. A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma. J Neurooncol. 1994;22:191–200
  38. Moriyama EH, Bisland SK, Bogaards A, Lilge L, Wilson BC. Bioluminescence monitoring of the response of rat gliosarcoma to ALA-PpIX-mediated photodynamic therapy. Photochem Photobiol. 2007;4:184–189
  39. Davies N, Wilson BC. Tetherless fiber-coupled optical sources for extended metronomic photodynamic therapy. Photodiagnosis and Photodynamic Therapy. 2004;80:242–249
  40. Davies-Shawhyde N. Metronomic photodynamic therapy as a treatment for malignant brain tumours. MSc thesis. University of Toronto, Department of Medical Biophysics; 2006.
  41. Contag CH, Ross BD. It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging. 2002;16:378–387
  42. Wang HW, Zhu TC, Putt ME, et al. Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy. J Biomed Opt. 2005;10:13998–14004
  43. Rice BW, Cable MD, Nelson MB. In vivo imaging of light-emitting probes. J Biomed Opt. 2001;6:432–440
  44. Van den Boogert J, van Staveren HJ, de Bruin RW, Siersema PD, van Hillegersberg R. Fractionated illumination for oesophageal ALA-PDT: effect on blood flow and PpIX formation. Lasers Med Sci. 2001;16:16–25
  45. Stefflova K, Chen J, Marotta D, Li H, Zheng G. Photodynamic therapy agent with a built-in apoptosis sensor for evaluating its own therapeutic outcome in situ. J Med Chem. 2006;29:3850–3856
  46. Wu Y, Xing D, Chen WR. Single cell FRET imaging for determination of pathway of tumor cell apoptosis induced by Photofrin-PDT. Cell Cycle. 2006;5:729–734
  47. Kasili PM, Vo-Dinh T. Optical nanobiosensor for monitoring an apoptotic signaling process in a single living cell following photodynamic therapy. J Nanosci Nanotechnol. 2005;5:2057–2062

PII: S1572-1000(07)00065-8

doi: 10.1016/j.pdpdt.2007.06.002

Photodiagnosis and Photodynamic Therapy
Volume 4, Issue 3 , Pages 202-212 , September 2007

Article Tools

* Image Usage & Resolution